Exo announced today that it appointed healthcare software veteran Kurt Hammond as its chief commercial officer (CCO).
Hammond, a more than 30-year veteran of healthcare software brand scaling, joins from eMed Digital Healthcare. As chief growth officer there, he oversaw sales, customer success, product management, marketing and partnership development functions.
Before eMed, he led six healthcare startups, including Halo Health and Merge Healthcare, to successful exits. His background includes more than 20 mergers and acquisitions in the healthcare market. After IBM acquired Merge in 2015, Hammond became VP of global imaging sales for IBM Watson Health. He eventually earned a promotion to global VP of partnerships and business development.
Santa Clara, California-based Exo says he now holds responsibility for developing and executing a number of strategies. Those include sales, marketing, partnerships and customer success, driving the commercialization of Exo’s integrated ultrasound system.
“With deep-rooted expertise in healthcare IT, SaaS and artificial intelligence, Kurt is the ideal leader to usher Exo into our next phase of growth. He shares our vision of bringing healthcare outside the constraints of hospital walls and uniquely understands the solutions required to make that a reality,” said Sandeep Akkaraju, co-founder and CEO of Exo. “As Exo expands its medical imaging ecosystem, Kurt’s experience leading market-altering health tech companies will be core to our success.”
More about the new CCO at Exo
Exo says Hammond’s appointment “comes at a pivotal time” in its aim to deliver simple and accessible medical imaging. The company has an end-to-end ultrasound system for providing immediate medical answers at the point of care. It launched its Exo Works point-of-care ultrasound workflow solution in March 2022.
The company also acquired FDA-cleared AI capabilities from Medo AI in July of last year and plans to commercialize a new handheld ultrasound. Built on proprietary technology, the pocket-sized device delivers high-performance imaging at a fraction of the cost of cart-based systems.
“Exo is the first company I’ve worked with that has dedicated the resources to bring a fully loaded, seamless platform to the healthcare market,” said Hammond. “The company has solved the massive technological and workflow issues caregivers experience when using modern point-of-care ultrasound solutions. This is only the beginning of Exo’s journey to disrupt medical imaging and I am proud to join a team so focused on creating a healthier and more equitable world.”
